Myelodysplasia is in the niche: novel concepts and emerging therapies.
about
Bone Marrow Immunity and MyelodysplasiaMesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the ClinicMissing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in ChildhoodSiltuximab (CNTO 328): a promising option for human malignanciesThe hematopoietic stem cell niche in homeostasis and diseaseOrigin of stem cells in the BM niche: new clues from mastocytosis.Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-RAnti-leukemic effects of the V-ATPase inhibitor Archazolid A.Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy.Zebrafish embryonic stromal trunk (ZEST) cells support hematopoietic stem and progenitor cell (HSPC) proliferation, survival, and differentiationEmerging biological therapies for the treatment of myelodysplastic syndromes.The crosstalk between long non-coding RNAs and PI3K in cancer.Differential profile of CDKN1A and TP53 expressions in bone marrow mesenchymal stromal cells from myeloid neoplasms.Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway.Personalized medicine in myelodysplastic syndromes: wishful thinking or already clinical reality?An abnormal secretion of soluble mediators contributes to the hematopoietic-niche dysfunction in low-risk myelodysplastic syndrome.Labile plasma iron levels predict survival in patients with lower-risk Myelodysplastic syndromes.A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory.Myelodysplastic syndromes and bone loss in mice and men.The bone-marrow niche in MDS and MGUS: implications for AML and MM.Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis.Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation.Selective quantitation of microvessel density reveals sinusoidal expansion in myelodysplastic syndromes.Usefulness of tocilizumab for treating rheumatoid arthritis with myelodysplastic syndrome: A case report and literature review.
P2860
Q26739239-388B37F8-8D7A-4BF1-812C-B6A24F7AFB15Q26746104-07CC8E43-D8F2-4FEE-A892-9199FAAC2E2EQ26752778-9DEEED04-AE58-4DD8-B588-94395B6CE3A1Q26798389-D31D3309-DA70-4ED7-B27D-A876A921875CQ28082572-B01EFEA6-7441-4711-AF25-6787129D9974Q28082775-E4FD5111-CED6-496B-8990-6D36D0C70D68Q36572914-DEBC5398-A0C7-4B1A-96D6-D5697DB38AD5Q37708743-4511FE5A-2717-46AA-B336-60131B6DF4AFQ38825585-C28B7059-6EF7-4F11-ABD0-E4B349F0F6CDQ38826127-C84C3F55-D3BA-4EAE-9EFC-0D556E83F21FQ38833769-9C29A8D5-363F-4147-979F-5DD5CCE8DB9EQ38834981-2F4CCD4A-A0E6-46F1-B77D-3B3CB9DA02D5Q38972951-B7FB422F-7B23-4A44-A011-D6D717178CBFQ42364661-F660191E-F93D-4B72-A5FE-118CDDA4C96AQ42517611-5DE1BA6A-67BD-4691-B47B-290F4E855635Q42573901-120BBC45-9C0B-4B2B-A3B4-E26DD0EBF4F2Q43142221-BDFA1944-263F-421A-95FF-A33789EB9DF1Q46264493-0904E997-0766-40C8-BE62-9926116EADD0Q46413457-8F504E76-D446-4B94-96BC-B6AFF7D52228Q48366330-94570F25-4CE4-4B34-A3B2-174C6E2E8D6FQ50114615-B4889716-2835-4500-AF15-310C90BAB18AQ50871377-F7F52DBC-BAD9-4A45-9F0A-A41A8920C30DQ52717549-A7CE0ED9-6D58-4966-AB65-A55F0DABF277Q52790846-5D3E3806-39B0-4842-ADE2-F552C82329F0Q54180808-D2999008-0089-4D5A-8038-311E3BB7BCA5Q55425307-B0E873DA-6B83-41F3-A97C-9147D64BBBDD
P2860
Myelodysplasia is in the niche: novel concepts and emerging therapies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Myelodysplasia is in the niche: novel concepts and emerging therapies.
@ast
Myelodysplasia is in the niche: novel concepts and emerging therapies.
@en
type
label
Myelodysplasia is in the niche: novel concepts and emerging therapies.
@ast
Myelodysplasia is in the niche: novel concepts and emerging therapies.
@en
prefLabel
Myelodysplasia is in the niche: novel concepts and emerging therapies.
@ast
Myelodysplasia is in the niche: novel concepts and emerging therapies.
@en
P2093
P2860
P50
P356
P1433
P1476
Myelodysplasia is in the niche: novel concepts and emerging therapies.
@en
P2093
M Bornhäuser
U Platzbecker
P2860
P2888
P304
P356
10.1038/LEU.2014.325
P577
2014-11-14T00:00:00Z
P5875
P6179
1033590706